Search results :

Clindamycin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D10AF01, G01AA10, J01FF01

Side effects

Options: Hide MedDRA Preferred Terms ,   display all 35 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Acne Acne 34% - 100% x x
Other acne x
Pimples
Exacerbation of acne
Erythema Erythema 0.595% - 86% x x x x x x x x
Redness x x
Localized erythema x
Seborrhoeic dermatitis Oily skin 1% - 26% x x x x x x
Seborrhoeic dermatitis postmarketing x
Skin exfoliation Localized exfoliation 0% - 61% x x x x x x x
Skin exfoliation x
Skin scaly x
Pruritus Pruritus postmarketing, 0.595% - 60% 0% x x x x x x x x x x x x x x x x x
Vulvovaginal candidiasis Vaginal moniliasis 1.5% - 13.3% 7.1% x x
Vulvovaginal mycotic infection Vaginal moniliasis 1.5% - 13.3% 7.1% x x
Application site pain Application site burn 6.15% - 9.09%
Application site pain postmarketing x x
Application site burn Application site burn 6.15% - 9.09%
Vulvovaginal disorder Vulvovaginal disorder 3.2% - 6.7% 7.1% x x
Vulvovaginitis Vulvovaginitis 4.4% - 6% x
Dysgeusia Taste bitter 5% x
Dysgeusia x x x
Taste metallic x x
Headache Headache 0.649% - 7.06% 2.35% x x x x x
Back pain Back pain 4.71% - 5% 1.18% x
Application site pruritus Application site pruritus 1.14% - 3.25%
Constipation Constipation 2% - 2.35% 0% x x x
Urinary tract infection Urinary tract infection 2% - 2.35% 0% x x x
Application site dryness Application site dryness 0.911% - 3.25%
Vomiting Vomiting 2% x x x x x x x x x x x x
Fungal infection Fungal infection 1% - 1.7% 0% x x x
Application site reaction Application site reaction 0.595% - 3.1% x
Sunburn Sunburn 1.19% x x
Photosensitivity reaction Sunburn 1.19% x x
Photosensitivity reaction 0% - 1.19%
Abnormal labour Abnormal labour 1.1% 0.5% x
Dyspnoea Dyspnoea 1% x
Body temperature increased Body temperature increased 1% x x
Hypotension Hypotension 1% x x x
Leukocytosis Leukocytosis 1% x
Vulvovaginal pain Vaginal pain postmarketing, 1.9% x x x x
Candida infection Candida infection 0.2% - 1.3% x x x
Vulvovaginitis trichomonal Trichomonal vaginitis 0% - 1.3% x x
Dermatitis Dermatitis 0% - 1.19%
Rash postmarketing, 7% x x x x x x x x x x x
Dermatitis contact Dermatitis contact 0% - 1.19% x x
Fungal skin infection Fungal skin infection 0% - 1.19%
Abdominal pain Abdominal pain postmarketing x x x x x x x x x x x x x x x x x x
Abdominal cramps x x x
Abdominal pain generalised x x
Abdominal pain localised x x x
Gastrointestinal pain Abdominal pain postmarketing x x x x x x x x x x x x x x x x x x
Colitis Colitis postmarketing x x x x x x x x x x
Diarrhoea Diarrhoea postmarketing x x x x x x x x x x x x x x x
Watery diarrhoea x
Dizziness Dizziness postmarketing x x x x
Rash Rash postmarketing, 7% x x x x x x x x x x x
Folliculitis Folliculitis postmarketing, 0% - 1.19% x x x x x x x x
Haematochezia Haematochezia postmarketing x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x
Nausea Nausea postmarketing, 2% x x x x x x x x x x x x x
Urticaria Urticaria postmarketing, 1% x x x x x x x x x x
Diarrhoea haemorrhagic Diarrhoea haemorrhagic postmarketing x x x x x x x
Vaginal discharge Vaginal discharge postmarketing x
Dyspepsia Digestion impaired postmarketing x x x x x x x
Dyspepsia x x x
Gastrointestinal disorder Digestion impaired postmarketing x x x x x x x
Gastrointestinal disorder x x
Gastrointestinal symptom NOS x
Abdominal discomfort Abdominal discomfort postmarketing x
Pain of skin Pain of skin postmarketing x
Vulvovaginal erythema Vaginal erythema postmarketing x
Vulval erythema x
Instillation site pain Application site pain postmarketing x x
Application site rash Application site rash postmarketing x
Vulvovaginal swelling Vaginal swelling postmarketing x
Application site erythema Application site erythema postmarketing x
Pseudomembranous colitis Pseudomembranous colitis postmarketing x x x x x x x x x x x
Vaginal haemorrhage Vaginal haemorrhage postmarketing x
Abscess Abscess x x
Agranulocytosis Agranulocytosis x x x x x x x x
Anaemia Anaemia
Bacterial infection Bacterial infection x x
Dermatitis exfoliative Dermatitis exfoliative x x x
Dysuria Dysuria x x x
Localised oedema Localised oedema x
Endometriosis Endometriosis x x
Eosinophilia Eosinophilia x x x x x x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis x
Epistaxis Epistaxis x x
Erythema multiforme Erythema multiforme x x x x x x x x
Stevens-Johnson syndrome x x x x x x x x
Oesophagitis Oesophagitis x x x x x x x
Asthenia Fatigue x
Fatigue Fatigue x
Flank pain Flank pain x
Flatulence Flatulence x x
Abdominal bloating x x
Flushing Flushing x
Breath odour Breath odour x x
Cardiac arrest Cardiac arrest x
Hypertension Hypertension x
Hyperthyroidism Hyperthyroidism x x
Jaundice Jaundice x x x x x x x x
Leukopenia Leukopenia x x x x x x x x
Measles Measles x
Menstrual disorder Menstrual disorder x x x
Metrorrhagia Metrorrhagia x x x
Muscle spasms Cramp muscle x
Neutropenia Neutropenia x x x x x x x x
Oliguria Oliguria x x x x x x x x
Pain Pain x x x x
Generalized aching x
Stinging x x x
Pelvic pain Pelvic pain x
Proteinuria Proteinuria x x x x x x x x
Protein urine present Proteinuria x x x x x x x x
Prurigo Prurigo x
Pyelonephritis Pyelonephritis x
Stevens-Johnson syndrome Stevens-Johnson syndrome x x x x x x x x
Superinfection Superinfection x
Swelling Swelling x
Thrombocytopenia Thrombocytopenia x x x x x x x x
Thrombophlebitis Thrombophlebitis x x x
Ulcer Ulcer x
Upper respiratory tract infection Upper respiratory tract infection x x
Vaginal inflammation Vaginal inflammation x x x x x
Vaginal infection Vaginal inflammation x x x x x
Vaginal infection x x x
Vertigo Vertigo x x
Vulvitis Vulvitis x
Clostridium difficile colitis Antibiotic associated colitis x x
Rash pustular Vesiculobullous rash x x
Dermatitis bullous Vesiculobullous rash x x
Dry skin Dry skin 0% - 12% x x x
Oesophageal ulcer Oesophageal ulcer x
Skin irritation Skin irritation x
Polyarthritis Polyarthritis x x x x x x x x
Discomfort Discomfort x
Tenderness Tenderness x
Rash erythematous Rash erythematous 0%
Inflammation Inflammatory swelling x x
Vulvovaginal burning sensation Burning feeling vagina x
Azotaemia Azotaemia x x x x x x x x
Induration Induration x x
Anaphylactic shock Anaphylactoid reaction x x x x x x x x
Anaphylactoid reaction Anaphylactoid reaction x x x x x x x x
Abdominal pain upper Stomach cramps x x
Rash maculo-papular Rash maculo-papular x x x x x x x
Vulvovaginal discomfort Vulvovaginal discomfort x
Vaginal irritation x
Vulvovaginal dryness Vulvovaginal dryness x
Injection site irritation Injection site irritation
Cardio-respiratory arrest Cardio-respiratory arrest x x
Local reaction Local reaction x x x
Acute generalised exanthematous pustulosis Acute generalised exanthematous pustulosis
Abdominal distension Abdominal bloating x x
Thrombophlebitis superficial Thrombophlebitis superficial x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CLINDAMYCIN

Side effects:6
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:7
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:8
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:8
Source:FDA Structured Product Label

Clindamycin

Side effects:11
Source:FDA Structured Product Label

clindamycin

Side effects:11
Source:FDA Structured Product Label

clindamycin

Side effects:11
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:20
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:25
Source:FDA Structured Product Label

CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) / TARO-CLINDAMYCIN

Side effects:27
Source:Health Canada

CLINDAMYCIN

Side effects:30
Source:FDA Structured Product Label

Clindamycin

Side effects:33
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:41
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:45
Source:FDA Structured Product Label

Clindamycin

Side effects:51
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:55
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label